£719k
−23%vs Dec 2024From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Azadyne Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Azadyne Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AZADYNE LTD is an active private limited company (company number 11740078) incorporated on 24 December 2018, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £719k and cash of £365k, with 2 employees on average. Net assets fell 23% on the prior period (£939k).
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Mr Jason Edward Rutt
- can appoint or remove directors
- Mr Stephen Joseph Cannon
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Vincent Patrick Kelly
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr John Michael Southern
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 24 December 20187 yrs ago
- Next accounts due
- 30 September 2027in 341 days
- Confirmation statement due
- 7 January 2027in 75 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£365k
−32%vs Dec 2024Not reported
2
−33%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £719k | £365k | — | £45k | — | — | 2 |
| 31 December 2024 | £939k | £537k | — | £49k | — | — | 3 |
Current ratio10.3Current assets ÷ creditors within one year
Cash per employee£183kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £718,786 at 31 December 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 10.3
- Cash at bank of £50,000 or moreCash £365,013
- Incorporated five or more years agoIncorporated 24 December 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 341 days
- Confirmation statement duein 75 days
- Accounts period endNet assets £719k · small accounts
- Accounts period endNet assets £939k · small accounts
- Incorporated
08
Similar companies in London
- BIOSEARLAB CICLondon · inc. Dec 2018
- IMMUNOSENSE LTDLondon · inc. Dec 2018
- EB THERAPEUTICS LTDLondon · inc. Dec 2018
- BEONE MEDICINES UK, LTD.London · inc. Dec 2018
- HEALTH INNOVATION HUB LIMITEDLondon · inc. Jan 2019
- FORMALISED CURIOSITIES LTDLondon · inc. Jan 2019
All companies incorporated on 24 December 2018 · in Dec 2018.
09
Reminders for AZADYNE LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.